Nanobiotix (NASDAQ:NBTX) Stock Jumps 7.9% – Here’s What Happened

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX)’s share price shot up 7.9% on Tuesday. The stock traded as high as $32.25 and last traded at $33.0390. 1,339 shares traded hands during trading, a decline of 99% from the average session volume of 99,621 shares. The stock had previously closed at $30.63.

Analysts Set New Price Targets

NBTX has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Nanobiotix in a research report on Thursday, October 15th. Guggenheim assumed coverage on Nanobiotix in a research report on Tuesday, September 15th. They set a “buy” rating and a $64.00 price target for the company. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.67.

Nanobiotix Stock Performance

The company’s fifty day moving average is $31.00 and its 200-day moving average is $33.99.

About Nanobiotix

Nanobiotix is a French biotechnology company developing nanoparticle-based treatments for cancer. Founded in 2003, the company focuses on using nanomedicine to enhance the effects of established cancer therapies, particularly radiation therapy.

Its lead product candidate, NBTXR3, is made from hafnium oxide nanoparticles and is designed to be injected directly into a tumor. When exposed to radiation, the particles are intended to increase damage to cancer cells while limiting the effect on surrounding healthy tissue.